GM-CSF regulates protein and lipid catabolism by alveolar macrophages.
暂无分享,去创建一个
[1] W. Lu,et al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[2] J. Whitsett,et al. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. , 1999, The Journal of clinical investigation.
[3] J. Whitsett,et al. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. , 1999, The Journal of clinical investigation.
[4] W. Watford,et al. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. , 1999, American journal of respiratory cell and molecular biology.
[5] Yoshitsugu Yamada,et al. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte‐macrophage colony stimulating factor , 1999, FEBS letters.
[6] U. Dirksen,et al. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis. , 1998, Blood.
[7] F. Burczynski,et al. Binding of [3H]palmitate to BSA. , 1998, The American journal of physiology.
[8] J. Whitsett,et al. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. , 1998, American journal of respiratory cell and molecular biology.
[9] J. Whitsett,et al. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice. , 1998, Human gene therapy.
[10] W. Rom,et al. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis. , 1997, American journal of respiratory and critical care medicine.
[11] U. Dirksen,et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. , 1997, The Journal of clinical investigation.
[12] R. Nishinakamura,et al. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 β c receptor-deficient mice despite correction of alveolar proteinosis after BMT , 1997, Bone Marrow Transplantation.
[13] G. Dranoff,et al. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[14] J. Whitsett,et al. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. , 1997, Journal of immunology.
[15] P. Tarr. Granulocyte-macrophage colony-stimulating factor and the immune system , 1996, Medical oncology.
[16] J. Whitsett,et al. Purification of a Cell-surface Receptor for Surfactant Protein A* , 1996, The Journal of Biological Chemistry.
[17] G. Dranoff,et al. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. , 1996, The American journal of physiology.
[18] V. Shepherd,et al. Differential regulation of the mannose and SP-A receptors on macrophages. , 1995, The American journal of physiology.
[19] C. Begley,et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Wright,et al. Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro. , 1995, The American journal of physiology.
[21] R. Nishinakamura,et al. Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL3 receptor-deficient mice are normal , 1995 .
[22] K. Arai,et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. , 1995, Immunity.
[23] A. Dunn,et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Dranoff,et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. , 1994, Science.
[25] A. Jobe,et al. Localization of alveolar surfactant clearance in rabbit lung cells. , 1992, The American journal of physiology.
[26] J. Wright,et al. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages. , 1992, The American journal of physiology.
[27] K. Drickamer,et al. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. , 1987, The Journal of biological chemistry.
[28] H. Reynolds,et al. Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients. Cytological data in normals and sarcoid patients. , 1986, European journal of respiratory diseases.
[29] H. Reynolds,et al. Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients: functional data in normals and sarcoid patients. , 1986, European journal of respiratory diseases.
[30] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[31] Raymond A. Dwek,et al. Principles and Problems in Physical Chemistry for Biochemists , 1974 .
[32] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.